Alexander Sikov
Halozyme Therapeutics (NASDAQ:HALO) on Thursday announced a lawsuit against Merck (NYSE:MRK) over allegations that an injectable version of the New Jersey-based pharma giant’s blockbuster cancer drug Keytruda has violated some of its patent rights.
The company alleged that Merck’s (